News

Researchers at Weill Cornell Medicine and Cornell's Ithaca campus have established a new center to better understand why health outcomes vary among demographic groups.

For Weill Cornell Medicine, 1998 was a banner year. Amid its centennial celebration, the academic medical institution renamed itself in deep appreciation for Joan and Sanford I. Weill and their exemplary leadership, launching a bright, new era of dynamic expansion. 

It’s not impossible to say Dr. Baran Ersoy was fated to help redefine how people can manage their weight gain and metabolism.

Strengthening state laws regulating firearms could help reduce the rates of both suicide and homicide, and the benefits could extend across state lines, a new study from an investigator at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine suggests.

The millions of cellular machines called ribosomes, which translate the genetic code carried by DNA into proteins, have long been thought to all be identical.

Cells in the nervous system can “put the brakes” on the immune response to infections in the gut and lungs to prevent excessive inflammation, according to research by Weill Cornell Medicine scientists.

As a student in the Tri-Institutional MD-PhD program, Dr. Joseph Heitman, MD ’92,  was thrilled to be training as a physician-scientist—someone who would be, as he puts it, an “ambassador” to bridge the sometimes disparate worlds of medicine and basic research.

Blood transfusions are historically one of the most common—and most overused—hospital procedures in the United States.

A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body’s intercellular delivery service to spread to new locations in the body.

To expand access to life-saving liver transplants for those in need, NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine have unveiled a new living donor liver transplant program. It performed its first such transplant with success in late January.

Bob Azopardi thought he only had months to live. After a routine physical, the 49-year-old was diagnosed with a type of cancer called chronic lymphocytic leukemia. 

A surgically implanted device used to regulate bladder and bowel control often requires additional operations to repair or replace it, according to a new study by Weill Cornell Medicine scientists.

Levetiracetam, the most commonly prescribed drug for U.S. infants with epilepsy, may be significantly more...

Scientists at the Sloan Kettering Institute and Weill Cornell Graduate School of Medical Sciences have developed a machine-learning approach to building personalized cancer nanomedicines. These tiny drug-filled particles help cancer medicines hit their target, making them more effective and causing fewer side effects.

Weill Cornell Medicine’s BioVenture eLab, a hub of the institution’s entrepreneurial activity celebrated a milestone on Jan. 23: the official launch of its new name and the opening of its dedicated space at 1157 York Ave.

Many successful researchers cite the influence of a mentor who inspired and advised them—and that’s especially true for Dr. Kevin O’Rourke, PhD ’17.

An enzyme found in brain cells can break apart the precursors to plaques that accumulate in the organ and cause toxicity in Alzheimer’s disease, according to a new study led by Weill Cornell Medicine scientists.

The modern concept of general anesthesia dates back to the 1840s, when doctors and dentists began giving patients ether before operations.